KLS-13019
Product Specifications
CAS Number
1801243-39-9
Target
Cannabinoid Receptor
Related Pathways
GPCR/G Protein
Purity
>99.99%
Bioactivity
KLS-13019 is a highly effective and orally active GPR55 receptor antagonist, a cannabidiol (CBD) -derived neuroprotective agent that can reverse chemotherapy-induced peripheral neuropathy (CIPN) and is suitable for studying hepatic encephalopathy (HE) .
Smiles
C(C)(=C)[C@H]1[C@@H](C=C(C)CC1)C2=C(O)C=C(CC3CN(C(C)=O)C3)C=C2O
Molecular Formula
C22H29NO3
Molecular Weight
355.47
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
abx232363 100 µg
Dehydrodolichyl Diphosphate Synthase Complex Subunit DHDDS (DHDDS) Antibody
Ask
View Details 
GTR15380280 1 Vial
Lentiviral human GTF2H1 sgRNA gene knockout kit - Lentiviral human GTF2H1 sgRNA gene knockout kit (25)
Ask
View Details 
